Nuwellis Inc (NUWE) COM USD0.0001

Sell:$1.24Buy:$1.25$0.02 (1.63%)

Prices delayed by at least 15 minutes
Sell:$1.24
Buy:$1.25
Change:$0.02 (1.63%)
Prices delayed by at least 15 minutes
Sell:$1.24
Buy:$1.25
Change:$0.02 (1.63%)
Prices delayed by at least 15 minutes

Company Information

About this company

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Key people

Nestor Jaramillo
President, Chief Executive Officer, Director
Robert B. Scott
Chief Financial Officer
Neil P. Ayotte
Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
John L. Erb
Non-Executive Chairman of the Board
Michael Mccormick
Lead Independent Director
Maria Rosa Costanzo
Independent Director
Archelle Georgiou
Independent Director
David Alan Mcdonald
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US67113Y6032
  • Market cap
    $5.29m
  • Employees
    59
  • Shares in issue
    4.37m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.